Remedium Lifecare P/E Ratio

Current P/E Ratio
40.5
High Valuation
Very High - High growth expectations or significantly overvalued

Remedium Lifecare (REMLIFE) P/E ratio is 40.5 (High), EPS (TTM) ₹0.05, current price ₹0.87 on BSE — Very High - High growth expectations or significantly overvalued. Analyse Remedium Lifecare shareholding analysis to track promoter, FII and institutional holdings.

Current Valuation Metrics

P/E Ratio 40.5
Current Price ₹0.87
EPS (TTM) ₹0.05
Exchange BSE

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 80.55
Sector Median 17.89
Sector Rank #11 of 254
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹0.10
Sept 2025 ₹0.10
Mar 2025 ₹-0.05

REMLIFE P/E Ratio — Valuation Signal & Historical Context

Remedium Lifecare P/E 40.5 — signal: Overvalued. Browse REMLIFE financial statements for revenue, profit, balance sheet and cash flow data.

  • Stock appears overvalued with PE of 40.5, suggesting caution for new investments
  • Trading at discount to sector average PE of 80.55

REMLIFE vs Commercial Services Peers — P/E Ratio Comparison

Remedium Lifecare P/E 40.5 vs Commercial Services average 80.55, median 17.89 — range 0.02–4335.0.

Sector Average
80.55
Sector Median
17.89
Lowest P/E
0.02
Highest P/E
4335.0
Companies
254
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Magnanimous Trade & Fina… MAGANTR 0.02 ₹1 Low
Gold Rock Investments ZGOLDINV 0.05 ₹1 Low
Satchmo Holdings SATCH 0.08 ₹85 Low
IMEC Services IMEC 0.1 ₹30 Low
Bentley Commercial Enterp BENTCOM 0.21 ₹0 Low
Bajaj Global BAJGLOB 0.23 ₹0 Low
Kusam Electrical Industr… KUSUMEL 0.31 ₹0 Low
Globe Commercials GLCL 0.42 ₹14 Low
Thakkers Group THAKKERS 0.55 ₹4 Low
Healthy Investments HEALINV 0.66 ₹0 Low